Cargando…
Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer London
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579170/ https://www.ncbi.nlm.nih.gov/pubmed/37592150 http://dx.doi.org/10.1007/s00198-023-06887-4 |
| _version_ | 1785121667232563200 |
|---|---|
| author | Everts-Graber, Judith Bonel, Harald Lehmann, Daniel Gahl, Brigitta Häuselmann, HansJörg Studer, Ueli Ziswiler, Hans-Rudolf Reichenbach, Stephan Lehmann, Thomas |
| author_facet | Everts-Graber, Judith Bonel, Harald Lehmann, Daniel Gahl, Brigitta Häuselmann, HansJörg Studer, Ueli Ziswiler, Hans-Rudolf Reichenbach, Stephan Lehmann, Thomas |
| author_sort | Everts-Graber, Judith |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10579170 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer London |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105791702023-10-18 Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study Everts-Graber, Judith Bonel, Harald Lehmann, Daniel Gahl, Brigitta Häuselmann, HansJörg Studer, Ueli Ziswiler, Hans-Rudolf Reichenbach, Stephan Lehmann, Thomas Osteoporos Int Correction Springer London 2023-08-18 2023 /pmc/articles/PMC10579170/ /pubmed/37592150 http://dx.doi.org/10.1007/s00198-023-06887-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Everts-Graber, Judith Bonel, Harald Lehmann, Daniel Gahl, Brigitta Häuselmann, HansJörg Studer, Ueli Ziswiler, Hans-Rudolf Reichenbach, Stephan Lehmann, Thomas Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study |
| title | Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study |
| title_full | Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study |
| title_fullStr | Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study |
| title_full_unstemmed | Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study |
| title_short | Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study |
| title_sort | correction to: comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579170/ https://www.ncbi.nlm.nih.gov/pubmed/37592150 http://dx.doi.org/10.1007/s00198-023-06887-4 |
| work_keys_str_mv | AT evertsgraberjudith correctiontocomparisonofantifractureeffectivenessofzoledronateibandronateandalendronateversusdenosumabinaregistrybasedcohortstudy AT bonelharald correctiontocomparisonofantifractureeffectivenessofzoledronateibandronateandalendronateversusdenosumabinaregistrybasedcohortstudy AT lehmanndaniel correctiontocomparisonofantifractureeffectivenessofzoledronateibandronateandalendronateversusdenosumabinaregistrybasedcohortstudy AT gahlbrigitta correctiontocomparisonofantifractureeffectivenessofzoledronateibandronateandalendronateversusdenosumabinaregistrybasedcohortstudy AT hauselmannhansjorg correctiontocomparisonofantifractureeffectivenessofzoledronateibandronateandalendronateversusdenosumabinaregistrybasedcohortstudy AT studerueli correctiontocomparisonofantifractureeffectivenessofzoledronateibandronateandalendronateversusdenosumabinaregistrybasedcohortstudy AT ziswilerhansrudolf correctiontocomparisonofantifractureeffectivenessofzoledronateibandronateandalendronateversusdenosumabinaregistrybasedcohortstudy AT reichenbachstephan correctiontocomparisonofantifractureeffectivenessofzoledronateibandronateandalendronateversusdenosumabinaregistrybasedcohortstudy AT lehmannthomas correctiontocomparisonofantifractureeffectivenessofzoledronateibandronateandalendronateversusdenosumabinaregistrybasedcohortstudy |